AGGRENOX DIN 02242119
Health Canada record
| Active ingredient(s) | DIPYRIDAMOLE 200 MG; ACETYLSALICYLIC ACID 25 MG |
|---|---|
| Dosage form | Capsule (Immediate- And Extended-Release |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AC30 COMBINATIONS |
| Original market date | 17-Apr-2000 |
| Current status date | 24-Feb-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIPYRIDAMOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02244475 | DIPYRIDAMOLE INJECTION, USP | FRESENIUS KABI CANADA LTD | Liquid | DIPYRIDAMOLE 5 MG | Marketed |
| 00637734 | PERSANTINE | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE | Solution | DIPYRIDAMOLE 5 MG | Marketed |
| 00895644 | APO-DIPYRIDAMOLE | APOTEX INC | Tablet | DIPYRIDAMOLE 25 MG | Cancelled Post Market |
| 02220571 | APO-DIPYRIDAMOLE | APOTEX INC | Tablet | DIPYRIDAMOLE 100 MG | Cancelled Pre Market |
| 00895660 | APO-DIPYRIDAMOLE | APOTEX INC | Tablet | DIPYRIDAMOLE 75 MG | Cancelled Post Market |
| 00895652 | APO-DIPYRIDAMOLE | APOTEX INC | Tablet | DIPYRIDAMOLE 50 MG | Cancelled Post Market |
| 00571237 | APO-DIPYRIDAMOLE-SC TAB 25MG | APOTEX INC | Tablet | DIPYRIDAMOLE 25 MG | Cancelled Post Market |
| 00571245 | APO-DIPYRIDAMOLE-SC TAB 50MG | APOTEX INC | Tablet | DIPYRIDAMOLE 50 MG | Cancelled Post Market |
| 00601845 | APO-DIPYRIDAMOLE-SC TAB 75MG | APOTEX INC | Tablet | DIPYRIDAMOLE 75 MG | Cancelled Post Market |
| 00579580 | DIPYRIDAMOLE 25 TAB 25MG | PRO DOC LIMITEE | Tablet | DIPYRIDAMOLE 25 MG | Cancelled Post Market |
| 00579572 | DIPYRIDAMOLE 50 TAB 50MG | PRO DOC LIMITEE | Tablet | DIPYRIDAMOLE 50 MG | Cancelled Post Market |
| 00598860 | DIPYRIDAMOLE 75 TAB | PRO DOC LIMITEE | Tablet | DIPYRIDAMOLE 75 MG | Cancelled Post Market |
| 02244909 | DIPYRIDAMOLE FOR INJECTION | NOVOPHARM LIMITED | Solution | DIPYRIDAMOLE 5 MG | Cancelled Post Market |
| 02229396 | DIPYRIDAMOLE-25 | PRO DOC LIMITEE | Tablet | DIPYRIDAMOLE 25 MG | Cancelled Post Market |
| 02229397 | DIPYRIDAMOLE-50 | PRO DOC LIMITEE | Tablet | DIPYRIDAMOLE 50 MG | Cancelled Post Market |
| 02229398 | DIPYRIDAMOLE-75 | PRO DOC LIMITEE | Tablet | DIPYRIDAMOLE 75 MG | Cancelled Post Market |
| 01907174 | NOVO-DIPIRADOL SCT 100MG | NOVOPHARM LIMITED | Tablet | DIPYRIDAMOLE 100 MG | Cancelled Post Market |
| 00784419 | NOVO-DIPIRADOL TAB 25MG | NOVOPHARM LIMITED | Tablet | DIPYRIDAMOLE 25 MG | Cancelled Post Market |
| 00784427 | NOVO-DIPIRADOL TAB 50MG | NOVOPHARM LIMITED | Tablet | DIPYRIDAMOLE 50 MG | Cancelled Post Market |
| 00784435 | NOVO-DIPIRADOL TAB 75MG | NOVOPHARM LIMITED | Tablet | DIPYRIDAMOLE 75 MG | Cancelled Post Market |
| 00452106 | PERSANTINE TAB 100MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | DIPYRIDAMOLE 100 MG | Cancelled Post Market |
| 00067385 | PERSANTINE TAB 25MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | DIPYRIDAMOLE 25 MG | Cancelled Post Market |
| 00067393 | PERSANTINE TAB 50MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | DIPYRIDAMOLE 50 MG | Cancelled Post Market |
| 00452092 | PERSANTINE TAB 75MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | DIPYRIDAMOLE 75 MG | Cancelled Post Market |
| 02471051 | TARO-DIPYRIDAMOLE/ ASA | TARO PHARMACEUTICALS INC | Capsule (Immediate- And Extended-Release | DIPYRIDAMOLE 200 MG; ACETYLSALICYLIC ACID 25 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1113 | 2000-04-13 | New Drug Submission (NDS) |
International API supply for DIPYRIDAMOLE
7 valid EDQM Certificates of Suitability from 7 holders. 8 active FDA Drug Master Files.
Request a quote for AGGRENOX